Active Ingredient: AZELASTINE HYDROCHLORIDE
Proprietary Name: AZELASTINE HYDROCHLORIDE
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 0.2055MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202743
Product Number: 001
Approval Date: May 8, 2014
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information